Is Anteris Technologies Global Corp. (NASDAQ:AVR) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Anteris Technologies Global Corp. at current levels.
A single-valve Australian upstart taking on Edwards and Medtronic with a design that actually mimics a healthy human aortic valve.
Where AVR is headed
The TAVR market has become a two-horse race between Edwards Lifesciences and Medtronic, with Boston Scientific's Acurate Neo2 pulled from the US after the failed ACURATE IDE. That is the setup Anteris walks into with DurAVR, the first biomimetic transcatheter aortic valve designed to reproduce the flow dynamics of a healthy native valve rather than approximate them. Early hemodynamic data has been genuinely striking: mean gradients in the 6-7 mmHg range, effective orifice areas above 2.2 cm², and laminar flow patterns that look nothing like the turbulence you see with Sapien or Evolut. In a market where the next competitive frontier is durability in younger patients (60s and low 70s getting TAVR instead of surgery), flow quality is the argument that matters.
Read the full Compass Direction on AVR
The complete destination call, the overlooked angle, milestones, and bull, base, and bear price scenarios (around $8.45).
See the full AVR analysisGet calls like this, free
Join the Alexandria e-letter for forward-looking verdicts, earnings intelligence, and the contrarian reads the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is Anteris Technologies Global Corp. (NASDAQ:AVR) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Anteris Technologies Global Corp. at current levels. A single-valve Australian upstart taking on Edwards and Medtronic with a design that actually mimics a healthy human aortic valve.
What is AVR's Compass Score?
Anteris Technologies Global Corp. scores 82/100 on Alexandria's Compass, placing it in the "True North" tier. Scores blend eight factors and update weekly.
What is the price target for AVR?
Alexandria's full Compass Direction includes bull, base, and bear price scenarios with the valuation math behind each. Read the full breakdown on the AVR page.
Compass verdicts are AI-generated, forward-looking editorial research from publicly available data, not investment advice or a recommendation regarding any security. Scores and verdicts update as the data changes.